The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 2, 2010, Pages 139-147

  Magierski, Radosław ^a   Kłoszewska, Iwona ^a   Sobów, Tomasz M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Alzheimer disease; Dementia with Lewy bodies; Mortality; Risk factors; Survival

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL HEALTH SERVICE; MINI MENTAL STATE EXAMINATION; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; VASCULAR DISEASE;

EID: 77952350925     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60005-0     Document Type: Article

References (26)

1. McKeith I., Mintzer J., Aarsland D., et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3: 19-28.
2. McKeith I.G., Galasko D., Wilcock G., et al. Lewy body dementia: diagnosis and treatment. Br J Psychiatry 1995; 167: 709-717.
3. Barber R., Panikkar A., McKeith I.G. Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry 2001; 16 (Suppl 1): S12-S18. (Pubitemid 33741564)
4. Zaccai J., McCracken C., Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 2005; 34: 561-566. (Pubitemid 41699997)
5. Sobów T., Wojtera M., Kłoszewska I. Charakterystyka kliniczna pacjentów konsultacyjnej Poradni Zaburzeń Pamiȩci Uniwersytetu Medycznego w Łodzi. Psychogeriatria Pol 2005; 2: 43-50.
6. Brookmeyer R., Corrada M.M., Curriero F.C., et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002; 59: 1764-1767. (Pubitemid 35340487)
7. Armstrong T.P., Hansen L.A., Salmon D.P., et al. Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease. Neurology 1991; 41: 1178-1180.
8. Olichney J.M., Galasko D., Salmon D.P., et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 1998; 51: 351-357. (Pubitemid 28406305)
9. Walker Z., Allen R.L., Shergill S., et al. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 2000; 15: 267-273. (Pubitemid 30179179)
10. Lopez O.L., Wisniewski S., Hamilton R.L., et al. Predictors of progression in patients with AD and Lewy bodies. Neurology 2000; 54: 1774-1779. (Pubitemid 30428404)
11. Williams M.M., Xiong C., Morris J.C., et al. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 2006; 67: 1935-1941. (Pubitemid 44967367)
12. McKeith I.G., Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
13. McKeith I.G., Perry E.K., Perry R.H. Report of the second dementia with Lewy body international workshop. Neurology 1999; 53: 902-905.
14. McKeith I.G., Dickson D.W., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005; 65: 1863-1872.
15. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
16. Ballard C., O'Brien J., Morris C.M., et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001; 16: 499-503. (Pubitemid 32492384)
17. Duron E., Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008; 4: 363-381. (Pubitemid 351711965)
18. Cechetto D.F., Hachinski V., Whitehead S.N. Vascular risk factors and Alzheimer's disease. Expert Rev Neurother 2008; 8: 743-750.
19. Lu F.-P., Lin K.-P., Kuo H.-K. Diabetes and the risk of multisystem aging phenotypes: a systematic review and meta-analysis. PLoS ONE 2009; 4: e4144. doi:10.1371/journal.pone.0004144.
20. Li L., Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007; 56: 384-402.
21. Götz J., Ittner L.M., Lim Y.A. Common features between diabetes mellitus and Alzheimer's disease. Cell Mol Life Sci 2009; 66: 1321-1325.
22. Galvin J.E., Lee V.M., Trojanowski J.Q. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001; 58: 186-190.
23. Galvin J.E. Dementia with Lewy bodies. Arch Neurol 2003; 60: 1332-1335.
24. Merdes A.R., Hansen L.A., Jeste D.V., et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003; 60: 1586-1590.
25. Magierski R., Sobow T., Karlinska I., et al. Clinical and neuropsychological predictors of the diagnosis of dementia with Lewy bodies. Arch Med Sci 2007; 3: 157-163.
26. Magierski R., Sobow T., Kloszewska I. Cholinesterase inhibitors tolerability study in dementia with Lewy bodies and Alzheimer's disease. P4-340; Alzheimer's & Dementia 2008, 4 (Suppl 2): T772.